Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

IntroductionTriple-negative breast cancer (TNBC) patients who do not obtain pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) present higher rate of relapse and worse overall survival. Risk factors for relapse in this subset of patients are poorly characterized. This study a...

Descrición completa

Detalles Bibliográficos

Principais autores:	Angela Toss, Marta Venturelli, Monica Civallero, Claudia Piombino, Federica Domati, Guido Ficarra, Francesca Combi, Eleonora Cabitza, Federica Caggia, Elena Barbieri, Monica Barbolini, Luca Moscetti, Claudia Omarini, Federico Piacentini, Giovanni Tazzioli, Massimo Dominici, Laura Cortesi
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Oncology
Assuntos:	triple-negative breast cancer neoadjuvant chemotherapy pathologic response residual cancer burden (RCB) multifocal disease
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1016295/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!